Molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities / submitted by Andrea Loipetzberger
ger: Cancer involves the aberrant activation of a limited set of signaling pathways regulating processes such as proliferation, survival, motility and stemness. Cooperative interactions of oncogenic signals play a critical role in malignant transformation. Our group has previously identified synergi...
Saved in:
VerfasserIn: | |
---|---|
Place / Publishing House: | 2015 |
Year of Publication: | 2015 |
Language: | English |
Subjects: | |
Classification: | 42.13 - Molekularbiologie 44.81 - Onkologie |
Online Access: | |
Physical Description: | 182 Bl.; Ill., graph. Darst.; 30 cm; 1 CD-ROM |
Notes: | Abweichender Titel laut Übersetzung der Verfasserin/des Verfassers |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
990003262460504498 |
---|---|
ctrlnum |
AC10778064 (AT-OBV)AC10778064 (Aleph)012344142ACC01 (DE-599)OBVAC10778064 (EXLNZ-43ACC_NETWORK)990123441420203331 |
collection |
bib_alma |
institution |
YWOAW |
building |
MAG1-3 |
record_format |
marc |
spelling |
Loipetzberger, Andrea aut Molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities submitted by Andrea Loipetzberger Molekulare Analyse von Pankreaskrebsstammzellen und neue therapeutische Möglichkeiten 2015 182 Bl. Ill., graph. Darst. 30 cm 1 CD-ROM Abweichender Titel laut Übersetzung der Verfasserin/des Verfassers Salzburg, Univ., Diss., 2015 ger: Cancer involves the aberrant activation of a limited set of signaling pathways regulating processes such as proliferation, survival, motility and stemness. Cooperative interactions of oncogenic signals play a critical role in malignant transformation. Our group has previously identified synergistic interactions of two clinically relevant drug targetable pathways, the Hedgehog (HH)/GLI and the EGFR pathway (Kasper, M., H. Schnidar, et al. (2006). Mol Cell Biol 26(16):<br />6283-6298.; Schnidar, H., M. Eberl, et al. (2009). Cancer Res 69(4):<br />1284-1292.).<br />We further showed that synergistic HH/GLI-EGFR signaling regulates a defined set of "synergistic target genes" that determines the malignant phenotype of pancreatic cancer cells (Eberl M., S.Klingler, et.al (2012). EMBO Mol Med.). During my PhD thesis, I analyzed the dependency of a tumor initiating subpopulation of pancreatic cancer on the HH/GLI-EGFR signal cooperation. Chemical or shRNA mediated perturbation of either pathway, as well as perturbation of synergistic target genes abolished the tumor initiating subpopulation in vitro and reduced in vivo tumor development of pancreatic cancer cells. Building on this data we could show a hierarchical signaling network of the synergistic HH/GLI-EGFR target genes in the process of tumor development.<br />Accordingly we tested different combined treatment approaches in vitro and in vivo to identify rationale targets for a more effective therapy.<br />In addition we used an unbiased proteomics/transcriptomics approach to identify 3 new putative treatment targets for pancreatic cancer.<br /> Bauchspeicheldrüsenkrebs s (DE-588)4004728-3 Krebszelle s (DE-588)4128704-6 Hedgehog-Signaltransduktion s AS0044612 Zink-Finger-Proteine s (DE-588)4326267-3 Epidermaler Wachstumsfaktor-Rezeptor s (DE-588)4271161-7 AT-OBV UBSRIC V:AT-OBV;B:AT-UBS application/pdf http://media.obvsg.at/AC10778064-1001 UBS Inhaltsverzeichnis OBV-EDOC YWOAW MAG1-3 43213-C.Stip. 2236394600004498 |
language |
English |
format |
Thesis Book |
author |
Loipetzberger, Andrea |
spellingShingle |
Loipetzberger, Andrea Molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities Bauchspeicheldrüsenkrebs (DE-588)4004728-3 Krebszelle (DE-588)4128704-6 Hedgehog-Signaltransduktion AS0044612 Zink-Finger-Proteine (DE-588)4326267-3 Epidermaler Wachstumsfaktor-Rezeptor (DE-588)4271161-7 |
author_facet |
Loipetzberger, Andrea |
author_variant |
a l al |
author_role |
VerfasserIn |
author_sort |
Loipetzberger, Andrea |
title |
Molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities |
title_full |
Molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities submitted by Andrea Loipetzberger |
title_fullStr |
Molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities submitted by Andrea Loipetzberger |
title_full_unstemmed |
Molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities submitted by Andrea Loipetzberger |
title_auth |
Molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities |
title_alt |
Molekulare Analyse von Pankreaskrebsstammzellen und neue therapeutische Möglichkeiten |
title_new |
Molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities |
title_sort |
molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities |
publishDate |
2015 |
physical |
182 Bl. Ill., graph. Darst. 30 cm 1 CD-ROM |
callnumber-raw |
43213-C.Stip. |
callnumber-search |
43213-C.Stip. |
topic |
Bauchspeicheldrüsenkrebs (DE-588)4004728-3 Krebszelle (DE-588)4128704-6 Hedgehog-Signaltransduktion AS0044612 Zink-Finger-Proteine (DE-588)4326267-3 Epidermaler Wachstumsfaktor-Rezeptor (DE-588)4271161-7 |
topic_facet |
Bauchspeicheldrüsenkrebs Krebszelle Hedgehog-Signaltransduktion Zink-Finger-Proteine Epidermaler Wachstumsfaktor-Rezeptor |
url |
http://media.obvsg.at/AC10778064-1001 |
illustrated |
Illustrated |
work_keys_str_mv |
AT loipetzbergerandrea molecularanalysisofpancreaticcancerstemcellsandnoveltherapeuticopportunities AT loipetzbergerandrea molekulareanalysevonpankreaskrebsstammzellenundneuetherapeutischemoglichkeiten |
status_str |
n |
ids_txt_mv |
(AT-OBV)AC10778064 AC10778064 (Aleph)012344142ACC01 (DE-599)OBVAC10778064 (EXLNZ-43ACC_NETWORK)990123441420203331 |
hol852bOwn_txt_mv |
YWOAW |
hol852hSignatur_txt_mv |
43213-C.Stip. |
hol852cSonderstandort_txt_mv |
MAG1-3 |
itmData_txt_mv |
2018-02-12 01:00:00 Europe/Vienna |
barcode_str_mv |
+YW21850507 +YW21850404 |
callnumbers_txt_mv |
43213-C.Stip. |
inventoryNumbers_str_mv |
2018-CD-582 2018-43213-C.Stip. |
materialTypes_str_mv |
BOOK |
permanentLibraries_str_mv |
YWOAW |
permanentLocations_str_mv |
MAG1-3 |
inventoryDates_str_mv |
20180212 |
createdDates_str_mv |
2018-02-12 01:00:00 Europe/Vienna |
holdingIds_str_mv |
2236394600004498 |
publicNotes_str_mv |
CD-Beil. zu 43213-C.Stip. CD-Beil. CD-582 |
is_hierarchy_id |
AC10778064 |
is_hierarchy_title |
Molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities |
basiskl_str_mv |
42.13 - Molekularbiologie 44.81 - Onkologie |
basiskl_txtF_mv |
42.13 - Molekularbiologie 44.81 - Onkologie |
_version_ |
1805534638432583680 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03608nam#a2200505#c#4500</leader><controlfield tag="001">990003262460504498</controlfield><controlfield tag="005">20230409173829.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">151005|2015####|||######m####|||#|#eng#c</controlfield><controlfield tag="009">AC10778064</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">OeBB</subfield><subfield code="2">oeb</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(AT-OBV)AC10778064</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">AC10778064</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Aleph)012344142ACC01</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)OBVAC10778064</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLNZ-43ACC_NETWORK)990123441420203331</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">UBS</subfield><subfield code="b">ger</subfield><subfield code="c">OPUS</subfield><subfield code="d">UBS</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="c">XA-AT</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.81</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Loipetzberger, Andrea</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Molecular analysis of pancreatic cancer stem cells and novel therapeutic opportunities</subfield><subfield code="c">submitted by Andrea Loipetzberger</subfield></datafield><datafield tag="246" ind1="3" ind2=" "><subfield code="a">Molekulare Analyse von Pankreaskrebsstammzellen und neue therapeutische Möglichkeiten</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">182 Bl.</subfield><subfield code="b">Ill., graph. Darst.</subfield><subfield code="c">30 cm</subfield><subfield code="e">1 CD-ROM</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Abweichender Titel laut Übersetzung der Verfasserin/des Verfassers</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="a">Salzburg, Univ., Diss., 2015</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">ger: Cancer involves the aberrant activation of a limited set of signaling pathways regulating processes such as proliferation, survival, motility and stemness. Cooperative interactions of oncogenic signals play a critical role in malignant transformation. Our group has previously identified synergistic interactions of two clinically relevant drug targetable pathways, the Hedgehog (HH)/GLI and the EGFR pathway (Kasper, M., H. Schnidar, et al. (2006). Mol Cell Biol 26(16):<br />6283-6298.; Schnidar, H., M. Eberl, et al. (2009). Cancer Res 69(4):<br />1284-1292.).<br />We further showed that synergistic HH/GLI-EGFR signaling regulates a defined set of "synergistic target genes" that determines the malignant phenotype of pancreatic cancer cells (Eberl M., S.Klingler, et.al (2012). EMBO Mol Med.). During my PhD thesis, I analyzed the dependency of a tumor initiating subpopulation of pancreatic cancer on the HH/GLI-EGFR signal cooperation. Chemical or shRNA mediated perturbation of either pathway, as well as perturbation of synergistic target genes abolished the tumor initiating subpopulation in vitro and reduced in vivo tumor development of pancreatic cancer cells. Building on this data we could show a hierarchical signaling network of the synergistic HH/GLI-EGFR target genes in the process of tumor development.<br />Accordingly we tested different combined treatment approaches in vitro and in vivo to identify rationale targets for a more effective therapy.<br />In addition we used an unbiased proteomics/transcriptomics approach to identify 3 new putative treatment targets for pancreatic cancer.<br /></subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Bauchspeicheldrüsenkrebs</subfield><subfield code="D">s</subfield><subfield code="0">(DE-588)4004728-3</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Krebszelle</subfield><subfield code="D">s</subfield><subfield code="0">(DE-588)4128704-6</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Hedgehog-Signaltransduktion</subfield><subfield code="D">s</subfield><subfield code="0">AS0044612</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Zink-Finger-Proteine</subfield><subfield code="D">s</subfield><subfield code="0">(DE-588)4326267-3</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Epidermaler Wachstumsfaktor-Rezeptor</subfield><subfield code="D">s</subfield><subfield code="0">(DE-588)4271161-7</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">AT-OBV</subfield><subfield code="5">UBSRIC</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">V:AT-OBV;B:AT-UBS</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://media.obvsg.at/AC10778064-1001</subfield><subfield code="x">UBS</subfield><subfield code="3">Inhaltsverzeichnis</subfield><subfield code="o">OBV-EDOC</subfield></datafield><datafield tag="970" ind1="1" ind2=" "><subfield code="c">27</subfield></datafield><datafield tag="970" ind1="2" ind2=" "><subfield code="d">HS-DISS</subfield></datafield><datafield tag="970" ind1="0" ind2=" "><subfield code="a">OPUS32614</subfield></datafield><datafield tag="971" ind1="1" ind2=" "><subfield code="a">Aberger, Fritz</subfield><subfield code="0">(DE-588)1082777838</subfield></datafield><datafield tag="971" ind1="1" ind2=" "><subfield code="a">Frischauf, Anna-Maria</subfield><subfield code="0">(DE-588)1083042394</subfield></datafield><datafield tag="971" ind1="3" ind2=" "><subfield code="a">2015-04</subfield></datafield><datafield tag="971" ind1="4" ind2=" "><subfield code="a">Dr. rer. nat.</subfield></datafield><datafield tag="971" ind1="5" ind2=" "><subfield code="a">Universität Salzburg</subfield><subfield code="b">Naturwissenschaftliche Fakultät</subfield><subfield code="c">Fachbereich Molekulare Biologie</subfield></datafield><datafield tag="971" ind1="8" ind2=" "><subfield code="a">Pankreaskrebs / Krebsstammzellen / Hedgehog / EGFR / Molekulare Analyse</subfield></datafield><datafield tag="971" ind1="9" ind2=" "><subfield code="a">pancreatic cancer / cancer stem cells / Hedgehog / EGFR / molecular analysis</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-07-25 07:05:47 Europe/Vienna</subfield><subfield code="d">20</subfield><subfield code="f">System</subfield><subfield code="c">marc21</subfield><subfield code="a">2018-12-24 05:18:06 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="HOL" ind1="8" ind2=" "><subfield code="b">YWOAW</subfield><subfield code="h"> 43213-C.Stip. </subfield><subfield code="c">MAG1-3</subfield><subfield code="8">2236394600004498</subfield></datafield><datafield tag="852" ind1="8" ind2=" "><subfield code="b">YWOAW</subfield><subfield code="c">MAG1-3</subfield><subfield code="h"> 43213-C.Stip. </subfield><subfield code="8">2236394600004498</subfield></datafield><datafield tag="ITM" ind1=" " ind2=" "><subfield code="9">2236394600004498</subfield><subfield code="e">1</subfield><subfield code="m">BOOK</subfield><subfield code="b">+YW21850507</subfield><subfield code="i">2018-CD-582</subfield><subfield code="2">MAG1-3</subfield><subfield code="z">CD-Beil. zu 43213-C.Stip.</subfield><subfield code="n">CD-582</subfield><subfield code="o">20180212</subfield><subfield code="8">2313924370004498</subfield><subfield code="f">02</subfield><subfield code="p">2018-02-12 01:00:00 Europe/Vienna</subfield><subfield code="h">43213-C.Stip.</subfield><subfield code="1">YWOAW</subfield><subfield code="q">2022-06-09 11:50:10 Europe/Vienna</subfield></datafield><datafield tag="ITM" ind1=" " ind2=" "><subfield code="9">2236394600004498</subfield><subfield code="e">1</subfield><subfield code="m">BOOK</subfield><subfield code="b">+YW21850404</subfield><subfield code="i">2018-43213-C.Stip.</subfield><subfield code="2">MAG1-3</subfield><subfield code="z">CD-Beil. CD-582</subfield><subfield code="o">20180212</subfield><subfield code="8">2313924380004498</subfield><subfield code="f">02</subfield><subfield code="p">2018-02-12 01:00:00 Europe/Vienna</subfield><subfield code="h">43213-C.Stip.</subfield><subfield code="1">YWOAW</subfield><subfield code="q">2022-06-09 11:50:10 Europe/Vienna</subfield></datafield></record></collection> |